XML 51 R27.htm IDEA: XBRL DOCUMENT v3.25.0.1
Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)
6 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Schedule of Consolidated Financial Statements

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

 

 

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

 

   As Reported   Adjustments   As Corrected 
   Three months ended December 31, 2023 
   As Reported   Adjustments   As Corrected 
             
Operating expenses               
General and administrative  $4,310,452   $106,264   $4,416,716 
Research and development   3,148,873    420,294    3,569,167 
Exploration   771,523    51,902    823,425 
Total operating expenses   8,230,848    578,460    8,809,308 
                
Net loss before other income (expense)  $(8,230,848)  $(578,460)  $(8,809,308)
                
Other income (expense)               
Amortization and accretion of financing costs  $(1,053,766)  $(78,492)  $(1,132,258)
Change in fair value of derivative liability   -    (229,472)   (229,472)
Total other income (expense)   (1,060,587)   (307,965)   (1,368,551)
                
Net loss attributable to common stockholders  $(9,291,435)  $(886,424)  $(10,177,859)
Net loss per share, basic and diluted  $(0.19)  $(0.02)  $(0.21)

 

   As Reported   Adjustments   As Corrected 
   Six months ended December 31, 2023 
   As Reported   Adjustments   As Corrected 
             
Operating expenses               
General and administrative  $7,259,298   $211,415   $7,470,713 
Research and development   5,304,187    1,878,831    7,183,018 
Exploration   2,051,305    122,040    2,173,345 
Total operating expenses   14,614,790    2,212,286    16,827,076 
                
Net loss before other income (expense)  $(14,614,790)  $(2,212,286)  $(16,827,076)
                
Other income (expense)               
Amortization and accretion of financing costs  $(1,760,497)  $(104,657)  $(1,865,154)
Change in fair value of derivative liability   -    (229,473)   (229,473)
Total other income (expense)   (1,908,630)   (334,130)   (2,242,760)
                
Net loss attributable to common stockholders  $(16,523,420)  $(2,546,416)  $(19,069,836)
Net loss per share, basic and diluted  $(0.35)  $(0.05)  $(0.40)

 

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

 

   As Reported   Adjustments   As Corrected 
   Three months ended December 31, 2023 
   As Reported   Adjustments   As Corrected 
             
Stockholders’ Equity               
                
Additional paid-in capital:               
Stock-based compensation expense   3,836,466    424,861    4,261,327 
Balance, December 31, 2023  $243,020,935   $2,380,621   $245,401,556 
                
Accumulated deficit               
Net loss for period   (9,291,435)   (886,424)   (10,177,859)
Balance, December 31, 2023  $(176,496,995)  $(3,399,350)  $(179,896,345)
                
Total stockholders’ equity               
Balance, December 31, 2023  $66,573,285   $(1,018,729)  $65,554,556 

 

 

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

 

   As Reported   Adjustments   As Corrected 
   Six months ended December 31, 2023 
   As Reported   Adjustments   As Corrected 
             
Stockholders’ Equity               
                
Additional paid-in capital:               
Stock-based compensation expense   5,757,908    1,872,688    7,630,596 
Balance, December 31, 2023  $243,020,935   $2,380,621   $245,401,556 
                
Accumulated deficit               
Net loss for period   (16,523,420)   (2,546,416)   (19,069,836)
Balance, December 31, 2023  $(176,496,995)  $(3,399,350)  $(179,896,345)
                
Total stockholders’ equity               
Balance, December 31, 2023  $66,573,285   $(1,018,729)  $65,554,556 

 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

 

   As Reported   Adjustments   As Corrected 
   Six months ended December 31, 2023 
   As Reported   Adjustments   As Corrected 
Operating Activities               
Net loss attributable to stockholders  $(16,523,420)  $(2,546,416)  $(19,069,836)
Adjustments to reconcile net loss to net cash used in operating activities:               
Amortization and accretion expense  $1,760,497   $104,657   $1,865,154 
Stock-based compensation   5,757,908    1,933,603    7,691,511 
Shares issued for professional services   (132)   (316)   (448)
Change in fair value of derivative liability   -    229,473    229,473 
Changes in operating assets and liabilities:               
Accounts payable and accrued liabilities  $2,164,539   $279,000   $2,443,539 
                
Net cash used in operating activities  $(7,418,700)  $-   $(7,418,700)